Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing

MT Newswires17:29 ET

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 27 07:00 ET

FDA Begins Review of Alnylam's SNDA for Expanded Amvuttra Use

Zacks Nov 26 08:35 ET

Scotiabank Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $310

Moomoo NewsNov 26 08:32 ET · Ratings

Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $280

Moomoo NewsNov 26 08:32 ET · Ratings

Scotiabank Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TipRanksNov 26 07:36 ET · Ratings